Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis
Xu Wang, Linlin Shi, Xinping Wang, et al.
International Journal of Biological Macromolecules (2019) Vol. 141, pp. 1013-1021
Closed Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Structural characterization of an inulin neoseries-type fructan from Ophiopogonis Radix and the therapeutic effect on liver fibrosis in vivo
Wei Liu, Linzhang Zhang, Wei Xia, et al.
Carbohydrate Polymers (2023) Vol. 327, pp. 121659-121659
Closed Access | Times Cited: 14
The gut-liver axis in fatty liver disease: role played by natural products
Ming Zhu, Xie Ruishi, Xu Linyi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway
Xiaodan Bao, Youying Tang, Yishan Lv, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112404-112404
Closed Access | Times Cited: 5
From ancient wisdom to modern science: Gut microbiota sheds light on property theory of traditional Chinese medicine
Yanan Yang, Jiaguo Zhan, Ying Cao, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 4, pp. 413-444
Closed Access | Times Cited: 5
Effects of traditional Chinese medicine polysaccharides on chronic diseases by modulating gut microbiota: A review
Xinyu Li, Rixiang Zhu, Qian Liu, et al.
International Journal of Biological Macromolecules (2024), pp. 136691-136691
Closed Access | Times Cited: 5
Beneficial effects ofDendrobium officinaleon metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway
Bo Li, Xinglishang He, Haiying Jin, et al.
Food & Function (2021) Vol. 12, Iss. 12, pp. 5524-5538
Closed Access | Times Cited: 31
Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review
Yaolian Hu, Jun He, Ping Zheng, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 7, pp. 862-872
Closed Access | Times Cited: 28
Lactobacillus plantarumHF02 alleviates lipid accumulation and intestinal microbiota dysbiosis in high‐fat diet‐induced obese mice
Haoran Chen, Haiding Zhao, Xiaofen Qi, et al.
Journal of the Science of Food and Agriculture (2023) Vol. 103, Iss. 9, pp. 4625-4637
Closed Access | Times Cited: 12
Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
Yu-Long Hu, Qiaoli Ma, Xiaoqiang Dong, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 12
Relationship among Chinese herb polysaccharide (CHP), gut microbiota, and chronic diarrhea and impact of CHP on chronic diarrhea
Hong Xue, Chunfeng Mei, Fengyun Wang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 10, pp. 5837-5855
Open Access | Times Cited: 12
The linkage of gut microbiota and the property theory of traditional Chinese medicine (TCM): Cold-natured and sweet-flavored TCMs as an example
Yanan Yang, Chongming Wu
Journal of Ethnopharmacology (2023) Vol. 306, pp. 116167-116167
Closed Access | Times Cited: 11
Moringa oleifera leaf polysaccharide regulates fecal microbiota and colonic transcriptome in calves
Chao Zhao, Hangfan Li, Chongya Gao, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127108-127108
Closed Access | Times Cited: 11
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 11
Delivery of polysaccharides from Ophiopogon japonicus (OJPs) using OJPs/chitosan/whey protein co-assembled nanoparticles to treat defective intestinal epithelial tight junction barrier
Chi Lin, Tai-Chih Kuo, Jing-Chi Lin, et al.
International Journal of Biological Macromolecules (2020) Vol. 160, pp. 558-570
Closed Access | Times Cited: 29
The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
Yijing Ren, Siyue Li, Zixuan Song, et al.
Nutrients (2022) Vol. 14, Iss. 11, pp. 2303-2303
Open Access | Times Cited: 18
Biodegradable Nanoparticles Prepared from Chitosan and Casein for Delivery of Bioactive Polysaccharides
Chi Lin, Fang-Yu Hsu, Wei‐Ting Lin, et al.
Polymers (2022) Vol. 14, Iss. 14, pp. 2966-2966
Open Access | Times Cited: 17
Bioactive Components of Chinese Herbal Medicines in the Treatment of Glucose and Lipid Metabolism Disorders: Evidence and Potential Mechanisms
Ying Zhang, Jiaming Ju, Lei Jiao, et al.
Engineering (2023) Vol. 29, pp. 73-82
Open Access | Times Cited: 10
Fructans
De-Chang Xu, Song Li, Xinyan Zong, et al.
Elsevier eBooks (2025), pp. 97-130
Closed Access
Steam explosion modified pea peptides alleviates hepatosteatosis by regulating lipid metabolism pathways and promoting autophagy
Jingjing Zhang, Lianjun Song, Tiange Li, et al.
Food Research International (2025) Vol. 208, pp. 116182-116182
Closed Access
Health benefits of medicinal plant natural products via microbiota-mediated different gut axes
Xiang Li, Yufan Liu, Ning Liu, et al.
Pharmacological Research (2025), pp. 107730-107730
Open Access
Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies
Wen-Wen Liu, Lei Wang, Jinmei Ou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3752-3752
Open Access
Advances in the study of Ophiopogon japonicus polysaccharides: structural characterization, bioactivity and gut microbiota modulation regulation
Jiani Li, Liquan Zhou, Zuowei Xiao
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
Xiang Chen, Menghan Liu, Jun Tang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11710-11710
Open Access | Times Cited: 16
Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment
Yanbo Wang, Zengbo Wang, Yang Wan, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Yanggan Jiangmei Formula alleviates hepatic inflammation and lipid accumulation in non-alcoholic steatohepatitis by inhibiting the NF-κB/NLRP3 signaling pathway
Yuanyuan Wu, Jingwen Zhou, Xinchen Zuo, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 3, pp. 224-234
Closed Access | Times Cited: 3

Scroll to top